|
Identification of twenty-one new mutations in the factor IX gene by SSCP analysis
|
journal
|
January 1999 |
|
Domain organization of membrane-bound factor VIII
|
journal
|
April 2013 |
|
The CDC Hemophilia A Mutation Project (CHAMP) Mutation List: A New Online Resource
|
journal
|
December 2012 |
|
Validation of macromolecular flexibility in solution by small-angle X-ray scattering (SAXS)
|
journal
|
May 2012 |
|
Restoring Low Resolution Structure of Biological Macromolecules from Solution Scattering Using Simulated Annealing
|
journal
|
June 1999 |
|
Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site.
|
journal
|
August 1994 |
|
Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII.
|
journal
|
March 1994 |
|
The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study.
|
journal
|
October 1992 |
|
The role of the first growth factor domain of human factor IXa in binding to platelets and in factor X activation.
|
journal
|
April 1992 |
|
Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator.
|
journal
|
October 1994 |
|
pH-dependent denaturation of thrombin-activated porcine factor VIII.
|
journal
|
January 1990 |
|
Binding of human factor VIII to phospholipid vesicles.
|
journal
|
January 1990 |
|
Factor IXa enhances reconstitution of factor VIIIa from isolated A2 subunit and A1/A3-C1-C2 dimer.
|
journal
|
February 1992 |
|
Activation of factor VIII and mechanisms of cofactor action
|
journal
|
March 2004 |
|
Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding
|
journal
|
August 1999 |
|
Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: A computational protein–protein docking and molecular dynamics refinement study
|
journal
|
September 2014 |
|
Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasis
|
journal
|
May 2019 |
|
Single-molecule measurement and bioinformatics analysis suggest a preferred orientation of human coagulation factor VIII on hydrophobic interfaces
|
journal
|
May 2019 |
|
Accurate SAXS Profile Computation and its Assessment by Contrast Variation Experiments
|
journal
|
August 2013 |
|
Disruption of Protein-Membrane Binding and Identification of Small-Molecule Inhibitors of Coagulation Factor VIII
|
journal
|
October 2004 |
|
Crystal Structure of Human Factor VIII: Implications for the Formation of the Factor IXa-Factor VIIIa Complex
|
journal
|
April 2008 |
|
Structural Basis of the Cofactor- and Substrate-Assisted Activation of Human Coagulation Factor IXa
|
journal
|
December 2009 |
|
MT1-MMP Binds Membranes by Opposite Tips of Its β Propeller to Position It for Pericellular Proteolysis
|
journal
|
February 2019 |
|
Membrane Interaction of the Factor VIIIa Discoidin Domains in Atomistic Detail
|
journal
|
September 2015 |
|
Structure of the Calcium Ion-Bound .gamma.-Carboxyglutamic Acid-Rich Domain of Factor IX
|
journal
|
September 1995 |
|
Specific membrane binding of factor VIII is mediated by O-phospho-L-serine, a moiety of phosphatidylserine
|
journal
|
September 1993 |
|
Kinetics of coagulation factor-X activation by platelet-bound factor IXa
|
journal
|
March 1990 |
|
Coordinate Binding Studies of the Substrate (Factor X) with the Cofactor (Factor VIII) in the Assembly of the Factor X Activating Complex on the Activated Platelet Surface
|
journal
|
August 2002 |
|
Contribution of Factor VIIIa A2 and A3-C1-C2 Subunits to the Affinity for Factor IXa in Factor Xase
|
journal
|
April 2004 |
|
The Interface between the EGF2 Domain and the Protease Domain in Blood Coagulation Factor IX Contributes to Factor VIII Binding and Factor X Activation
|
journal
|
August 2006 |
|
Directed Self-Assembly of Monodisperse Phospholipid Bilayer Nanodiscs with Controlled Size
|
journal
|
March 2004 |
|
Elliptical Structure of Phospholipid Bilayer Nanodiscs Encapsulated by Scaffold Proteins: Casting the Roles of the Lipids and the Protein
|
journal
|
October 2010 |
|
Thermotropic Phase Transition in Soluble Nanoscale Lipid Bilayers
|
journal
|
August 2005 |
|
Assembly of phospholipid nanodiscs of controlled size for structural studies of membrane proteins by NMR
|
journal
|
December 2017 |
|
Solution structure of discoidal high-density lipoprotein particles with a shortened apolipoprotein A-I
|
journal
|
December 2016 |
|
Phosphatidylethanolamine-phosphatidylserine binding synergy of seven coagulation factors revealed using Nanodisc arrays on silicon photonic sensors
|
journal
|
October 2020 |
|
Dimeric Organization of Blood Coagulation Factor VIII bound to Lipid Nanotubes
|
journal
|
June 2015 |
|
Deciphering conformational transitions of proteins by small angle X-ray scattering and normal mode analysis
|
journal
|
January 2016 |
|
Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa
|
journal
|
July 2004 |
|
Molecular orientation of Factor VIIIa on the phospholipid membrane surface determined by fluorescence resonance energy transfer
|
journal
|
May 2013 |
|
Changes in the Factor VIII C2 domain upon membrane binding determined by hydrogen–deuterium exchange MS
|
journal
|
July 2014 |
|
Binding of human blood-coagulation Factors IXa and X to phospholipid membranes
|
journal
|
November 1984 |
|
The interaction of bovine factor IX, its activation intermediate, factor IX α, and its activation products, factor IXaα and factor IXaβ, with acidic phospholipid vesicles of various compositions
|
journal
|
June 1986 |
|
The preparation and phospholipid binding property of the C2 domain of human factor VIII
|
journal
|
January 2003 |
|
The First Intrinsic Tenase Complex Inhibitor with Serine Protease Structure Offers a New Perspective in Anticoagulant Therapy
|
journal
|
September 2018 |
|
Venous Thrombosis in Acquired Hemophilia: The Complex Management of Competing Pathologies
|
journal
|
October 2019 |
|
X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua)
|
journal
|
October 2009 |
|
Discovery of an intrinsic tenase complex inhibitor: Pure nonasaccharide from fucosylated glycosaminoglycan
|
journal
|
June 2015 |
|
Hemophilia A due to mutations that create new N-glycosylation sites.
|
journal
|
June 1992 |
|
First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.
|
journal
|
April 1994 |
|
X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.
|
journal
|
October 1995 |
|
Model for the Factor VIIIa-dependent Decay of the Intrinsic Factor Xase
|
journal
|
March 1996 |
|
Activation of the Factor VIIIa-Factor IXa Enzyme Complex of Blood Coagulation by Membranes Containing Phosphatidyl-L-serine
|
journal
|
May 1996 |
|
The Sequence Glu1811-Lys1818 of Human Blood Coagulation Factor VIII Comprises a Binding Site for Activated Factor IX
|
journal
|
January 1996 |
|
The Acidic Region of the Factor VIII Light Chain and the C2 Domain Together Form the High Affinity Binding Site for von Willebrand Factor
|
journal
|
July 1997 |
|
Blood Coagulation Factor IX Residues Glu78 and Arg94 Provide a Link between Both Epidermal Growth Factor-like Domains That Is Crucial in the Interaction with Factor VIII Light Chain
|
journal
|
January 1998 |
|
Changing Residue 338 in Human Factor IX from Arginine to Alanine Causes an Increase in Catalytic Activity
|
journal
|
May 1998 |
|
The A2 Subunit of Factor VIIIa Modulates the Active Site of Factor IXa
|
journal
|
July 1998 |
|
Activation of Factor VIII by Thrombin Increases Its Affinity for Binding to Synthetic Phospholipid Membranes and Activated Platelets
|
journal
|
October 1998 |
|
Structural and Functional Characterization of Platelet Receptor-mediated Factor VIII Binding
|
journal
|
April 2000 |
|
Factor IXa:Factor VIIIa Interaction
|
journal
|
May 2001 |
|
Identification of Functionally Important Residues of the Epidermal Growth Factor-2 Domain of Factor IX by Alanine-scanning Mutagenesis
|
journal
|
July 2002 |
|
The Factor IXa Second Epidermal Growth Factor (EGF2) Domain Mediates Platelet Binding and Assembly of the Factor X Activating Complex
|
journal
|
February 2002 |
|
The Connecting Segment between Both Epidermal Growth Factor-like Domains in Blood Coagulation Factor IX Contributes to Stimulation by Factor VIIIa and Its Isolated A2 Domain
|
journal
|
June 2002 |
|
Mass Spectrometry-assisted Study Reveals That Lysine Residues 1967 and 1968 Have Opposite Contribution to Stability of Activated Factor VIII
|
journal
|
January 2012 |
|
Factor VIIIa A2 Subunit Shows a High Affinity Interaction with Factor IXa
|
journal
|
May 2013 |
|
Replacing the Factor VIII C1 Domain with a Second C2 Domain Reduces Factor VIII Stability and Affinity for Factor IXa
|
journal
|
October 2013 |
|
A3 Domain Region 1803–1818 Contributes to the Stability of Activated Factor VIII and Includes a Binding Site for Activated Factor IX
|
journal
|
September 2013 |
|
High Level Expression of Recombinant Porcine Coagulation Factor VIII
|
journal
|
October 2002 |
|
Physiological fIXa Activation Involves a Cooperative Conformational Rearrangement of the 99-Loop
|
journal
|
February 2003 |
|
The Gla Domain of Factor IXa Binds to Factor VIIIa in the Tenase Complex
|
journal
|
August 2003 |
|
Identification of Porcine Coagulation Factor VIII Domains Responsible for High Level Expression via Enhanced Secretion
|
journal
|
February 2004 |
|
Identification of Residues Asn89, Ile90, and Val107 of the Factor IXa Second Epidermal Growth Factor Domain That Are Essential for the Assembly of the Factor X-activating Complex on Activated Platelets
|
journal
|
November 2004 |
|
A1 Subunit-mediated Regulation of Thrombin-activated Factor VIII A2 Subunit Dissociation
|
journal
|
May 2006 |
|
The Factor VIIIa C2 Domain (Residues 2228–2240) Interacts with the Factor IXa Gla Domain in the Factor Xase Complex
|
journal
|
December 2008 |
|
Haemophilia A: database of ncleotide substituttions, deletions, insertions and rearrangements of the factor VIII gene
|
journal
|
January 1991 |
|
The RosettaDock server for local protein-protein docking
|
journal
|
May 2008 |
|
FoXS, FoXSDock and MultiFoXS: Single-state and multi-state structural modeling of proteins and their complexes based on SAXS profiles
|
journal
|
May 2016 |
|
SWISS-MODEL: homology modelling of protein structures and complexes
|
journal
|
May 2018 |
|
Engineering extended membrane scaffold proteins for self-assembly of soluble nanoscale lipid bilayers
|
journal
|
September 2010 |
|
Uniqueness of ab initio shape determination in small-angle scattering
|
journal
|
April 2003 |
|
PRIMUS: a Windows PC-based system for small-angle scattering data analysis
|
journal
|
September 2003 |
|
Determination of the regularization parameter in indirect-transform methods using perceptual criteria
|
journal
|
August 1992 |
|
Small-angle scattering determination of the shape and localization of human cytochrome P450 embedded in a phospholipid nanodisc environment
|
journal
|
November 2015 |
|
Quantifying radiation damage in biomolecular small-angle X-ray scattering
|
journal
|
May 2016 |
|
Interpretation of solution scattering data from lipid nanodiscs
|
journal
|
February 2018 |
|
Detection of new mutations and molecular pathology of mild and moderate haemophilia A patients from southern Brazil
|
journal
|
May 2013 |
|
Molecular models of the procoagulant Factor VIIIa–Factor IXa complex
|
journal
|
September 2005 |
|
Generation of a novel factor IX with augmented clotting activities in vitro and in vivo
|
journal
|
August 2010 |
|
Hemophilia B: molecular pathogenesis and mutation analysis
|
journal
|
July 2015 |
|
Lipid specificity of the membrane binding domain of coagulation factor X
|
journal
|
October 2017 |
|
Sodium‐site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study
|
journal
|
April 2019 |
|
The 3.2 Å structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain
|
journal
|
September 2019 |
|
Probing activation‐driven changes in coagulation factor IX by mass spectrometry
|
journal
|
June 2021 |
|
Incorporation of the factor IX Padua mutation into FIX-Triple improves clotting activity in vitro and in vivo
|
journal
|
January 2013 |
|
Factor VIII organisation on nanodiscs with different lipid composition
|
journal
|
July 2015 |
|
Emerging Anticoagulant Drugs
|
journal
|
April 2007 |
|
Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity
|
journal
|
August 2012 |
|
Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis
|
journal
|
October 2013 |
|
Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine
|
journal
|
September 2015 |
|
Contribution of Factor VIII A3 Domain Residues 1793-1795 to a Factor IXa-Interactive Site
|
journal
|
November 2018 |
|
Factor VIII–driven changes in activated factor IX explored by hydrogen-deuterium exchange mass spectrometry
|
journal
|
December 2020 |
|
Gene Therapy For Hemophilia B Using CB 2679d-GT: A Novel Factor IX Variant With Higher Potency Than Factor IX Padua
|
journal
|
March 2021 |
|
Structure of Blood Coagulation Factor VIII in Complex with an Anti-C1 Domain Pathogenic Antibody Inhibitor
|
journal
|
February 2021 |
|
3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography
|
journal
|
February 2002 |
|
Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants
|
journal
|
March 2021 |
|
Benchmarking and Analysis of Protein Docking Performance in Rosetta v3.2
|
journal
|
August 2011 |
|
Serverification of Molecular Modeling Applications: The Rosetta Online Server That Includes Everyone (ROSIE)
|
journal
|
May 2013 |
|
The 1.7 Å X-Ray Crystal Structure of the Porcine Factor VIII C2 Domain and Binding Analysis to Anti-Human C2 Domain Antibodies and Phospholipid Surfaces
|
journal
|
March 2015 |
|
Reversible stacking of lipid nanodiscs for structural studies of clotting factors
|
journal
|
February 2017 |
|
Factor VIII Structure and Function
|
journal
|
February 2006 |
|
Factor IX alteration p.Arg338Gln (FIX Shanghai) potentiates FIX clotting activity and causes thrombosis
|
journal
|
February 2020 |
|
Structure of Blood Coagulation Factor VIII in Complex With an Anti-C2 Domain Non-Classical, Pathogenic Antibody Inhibitor
|
journal
|
June 2021 |
|
Structure and dynamics of a nanodisc by integrating NMR, SAXS and SANS experiments with molecular dynamics simulations
|
journal
|
July 2020 |